Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 5INDUSTRY 4NIH 3OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Carcinoma, Hepatocellular 3Thyroid Neoplasms 1Small Cell Lung Carcinoma 1Neoplasms 1Liver Neoplasms 1Carcinoma 1

Interventions

Iodine-131 2Thyroxine 1Thyroidectomy 1Surgical Procedures, Operative 1Sorafenib 1Radiotherapy, Intensity-Modulated 1Iodine-123 1Anterior Temporal Lobectomy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Thyroid Neoplasms × Sorafenib × Clear all
NCT02084732 2019-11-13

Safety and Efficacy of Sorafenib in Patients With Advanced Thyroid Cancer: a Phase II Clinical Study

Instituto Nacional de Cancerologia, Columbia

Phase 2 Completed
35 enrolled
Head & Neck

Thyroid Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡